VT vs. PBPH
VT (Vanguard Total World Stock ETF) and PBPH (Portfolio Building Block World Pharma and Biotech Index ETF) are both exchange-traded funds - VT is a Global Equities fund tracking the FTSE Global All Cap Index, while PBPH is a Health & Biotech Equities fund tracking the BITA Global Pharma and Biotech Select Index. Both are passively managed. At a 0.46 correlation, their price movements are largely independent. VT charges 0.06%/yr vs 0.13%/yr for PBPH.
Performance
VT vs. PBPH - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, VT achieves a 12.24% return, which is significantly higher than PBPH's -1.13% return.
VT
- 1D
- -0.88%
- 1M
- 4.91%
- YTD
- 12.24%
- 6M
- 13.14%
- 1Y
- 29.24%
- 3Y*
- 20.93%
- 5Y*
- 10.99%
- 10Y*
- 12.74%
PBPH
- 1D
- 0.58%
- 1M
- 0.07%
- YTD
- -1.13%
- 6M
- -0.02%
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
VT vs. PBPH - Yearly Performance Comparison
| 2026 (YTD) | 2025 | |
|---|---|---|
VT Vanguard Total World Stock ETF | 12.24% | 2.24% |
PBPH Portfolio Building Block World Pharma and Biotech Index ETF | -1.13% | 0.76% |
Correlation
The correlation between VT and PBPH is 0.46, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (All Time) Calculated using the full available price history since Nov 26, 2025 | 0.46 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
VT vs. PBPH — Risk / Return Rank
VT
PBPH
VT vs. PBPH - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Vanguard Total World Stock ETF (VT) and Portfolio Building Block World Pharma and Biotech Index ETF (PBPH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| VT | PBPH | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | — | — | |
| Sortino ratioReturn per unit of downside risk | — | — | |
| Omega ratioGain probability vs. loss probability | 1.42 | — | — |
| Calmar ratioReturn relative to maximum drawdown | 3.04 | — | — |
| Martin ratioReturn relative to average drawdown | 13.53 | — | — |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| VT | PBPH | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 2.31 | — | — |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.69 | — | — |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.74 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.44 | -0.04 | +0.48 |
Drawdowns
VT vs. PBPH - Drawdown Comparison
The maximum VT drawdown since its inception was -50.27%, which is greater than PBPH's maximum drawdown of -11.10%. Use the drawdown chart below to compare losses from any high point for VT and PBPH.
Loading charts...
Drawdown Indicators
| VT | PBPH | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -50.27% | -11.10% | -39.17% |
Max Drawdown (1Y)Largest decline over 1 year | -9.67% | — | — |
Max Drawdown (3Y)Largest decline over 3 years | -16.51% | — | — |
Max Drawdown (5Y)Largest decline over 5 years | -26.38% | — | — |
Max Drawdown (10Y)Largest decline over 10 years | -34.24% | — | — |
Current DrawdownCurrent decline from peak | -0.88% | -8.69% | +7.81% |
Average DrawdownAverage peak-to-trough decline | -7.02% | -4.23% | -2.79% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 2.17% | — | — |
Volatility
VT vs. PBPH - Volatility Comparison
Loading charts...
Volatility by Period
| VT | PBPH | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 3.83% | — | — |
Volatility (6M)Calculated over the trailing 6-month period | 10.17% | — | — |
Volatility (1Y)Calculated over the trailing 1-year period | 12.70% | 16.78% | -4.08% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 16.05% | 16.78% | -0.73% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 17.23% | 16.78% | +0.45% |
VT vs. PBPH - Expense Ratio Comparison
VT has a 0.06% expense ratio, which is lower than PBPH's 0.13% expense ratio. Despite the difference, both funds are considered low-cost compared to the broader market, where average expense ratios usually range from 0.3% to 0.9%.
Dividends
VT vs. PBPH - Dividend Comparison
VT's dividend yield for the trailing twelve months is around 1.59%, more than PBPH's 0.09% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
PBPH Portfolio Building Block World Pharma and Biotech Index ETF | 0.09% | 0.09% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
VT Vanguard Total World Stock ETF | 1.59% | 1.82% | 1.95% | 2.08% | 2.20% | 1.82% | 1.66% | 2.32% | 2.53% | 2.11% | 2.39% | 2.45% |
Frequently Asked Questions
VT and PBPH have a correlation of 0.46, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, VT is cheaper at 0.06% per year. The better choice depends on whether you care most about return, fees, risk, or income.
VT is cheaper with a 0.06% expense ratio, compared with 0.13% for PBPH.
VT has the higher dividend yield at 1.59%, compared with 0.09% for PBPH.
VT is categorized as Global Equities, while PBPH is Health & Biotech Equities. VT tracks FTSE Global All Cap Index, while PBPH tracks BITA Global Pharma and Biotech Select Index. They also come from different issuers: Vanguard and Portfolio Building Block. Their fees differ too: 0.06% for VT and 0.13% for PBPH.
Find the right allocation for VT and PBPH
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer